Literature DB >> 407250

Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.

M Pollack, N S Taylor.   

Abstract

A passive hemagglutination (PHA) assay for antibody to Pseudomonas aeruginosa exotoxin is described which utilizes chromic chloride-treated ovine erythrocytes coated with purified toxin. PHA antitoxin titers correlated well with those obtained by a cytotoxicity neutralization assay (r = 0.91, P less than 0.001), whereas the PHA assay was four to eight times as sensitive. The mean serum PHA titer of 16 patients convalescing from recent pseudomonas infections (log2 = 9.4 +/- 3.9) was significantly higher (P less than 0.001) than that of 17 healthy controls (2,7 +/- 2.6), and fourfold or greater rises were demonstrated in 5 of 7 patients examined sequentially. The lower levels of PHA antibody in sera from 11 of 17 controls suggested the acquisition of antitoxin secondary to asymptomatic infection.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407250      PMCID: PMC274698          DOI: 10.1128/jcm.6.1.58-61.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Chromic chloride: a coupling reagent for passive hemagglutination reactions.

Authors:  E R Gold; H H Fudenberg
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

2.  A new rapid method for genetic typing of human immunoglobulins.

Authors:  G N Vyas; H H Fudenberg; H M Pretty; E R Gold
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

3.  Purification and characterization of Pseudomonas aeruginosa exotoxin.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

4.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

5.  Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

6.  Exotoxin production by clinical isolates of pseudomonas aeruginosa.

Authors:  M Pollack; N S Taylor; L T Callahan
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

  6 in total
  14 in total

1.  Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography.

Authors:  N S Taylor; M Pollack
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

2.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

3.  Enzyme-linked immunosorbent assay for Pseudomonas aeruginosa exotoxin A.

Authors:  W W Schultz; T J Phipps; M Pollack
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

4.  Production of exotoxin A by Pseudomonas aeruginosa in a chemically defined medium.

Authors:  R M DeBell
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2.

Authors:  O R Pavlovskis; B H Iglewski; M Pollack
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

6.  Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

Authors:  M Pollack; L S Young
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

7.  Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera.

Authors:  T L Pitt; H C Todd; C A Mackintosh; S W Im
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

8.  Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages.

Authors:  M Pollack; S E Anderson
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

9.  Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.

Authors:  K Snell; I A Holder; S A Leppla; C B Saelinger
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.

Authors:  M Pollack; A I Huang; R K Prescott; L S Young; K W Hunter; D F Cruess; C M Tsai
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.